# A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

> **NCT00605826** · NA · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 206 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DEVICE:** NASHA/Dx (Solesta) Gel
- **DEVICE:** Sham Injection

## Key facts

- **NCT ID:** NCT00605826
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-07
- **Primary completion:** 2009-11-23
- **Final completion:** 2009-11-23
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2020-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605826, "A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00605826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*